Skip to main content
. 2023 Jan 12;10:1040012. doi: 10.3389/fpubh.2022.1040012

Table 2.

Variant analysis* in COVID-19 patients with or without H/O vaccination.

No of vaccine doses (No of recipients) Wild (Wuhan) kappa Delta Alpha
One dose (84) 2 (2.3%) 26 (30.9%) 56 (66.6%) 0
2 doses (42) 0 13 (30.95%) 29 (69.05%) 0
None (168) 4 (2.38%) 41 (24.4%) 117 (69.65%) 1(0.59%)
*

Six (3 each in 1 and 2 doses recipients) sequences exhibited V382L mutation while 3 among the non-vaccinated group exhibited N440K mutation.